These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4106032)

  • 1. Dissimilarity of human vascular plasminogen activator and human urokinase.
    Aoki N; Von Kaulla KN
    J Lab Clin Med; 1971 Sep; 78(3):354-62. PubMed ID: 4106032
    [No Abstract]   [Full Text] [Related]  

  • 2. "Angiokinase"--molecular weights of proteins representing a perivascular plasminogen activator.
    Auerswald W; Binder B; Doleschel W
    Thromb Diath Haemorrh; 1971 Oct; 26(2):411-3. PubMed ID: 5134490
    [No Abstract]   [Full Text] [Related]  

  • 3. Preparation of plasminogen activator from vascular trees of human cadavers. Its comparison with urokinase.
    Aoki N
    J Biochem; 1974 Apr; 75(4):731-41. PubMed ID: 4847212
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasminogen-activator in human early milk: its partial purification and characterization.
    Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
    Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the activation mechanism of fibrinolytic enzyme system in plasma by human pancreatic elastase.
    Toki N; Takasugi S; Ishizu K; Sato H; Sumi H
    Thromb Haemost; 1982 Feb; 47(1):8-13. PubMed ID: 6176043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase.
    Duckert F
    Curr Probl Clin Biochem; 1968; 2():237-59. PubMed ID: 4950372
    [No Abstract]   [Full Text] [Related]  

  • 8. An enhancing effect of poly-lysine on the activation of plasminogen.
    Allen RA
    Thromb Haemost; 1982 Feb; 47(1):41-5. PubMed ID: 7200268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic identity of plasminogen activator in human urine, heart, blood vessels, and tissue culture.
    Bernik MB; White WF; Oller EP; Kwaan HC
    J Lab Clin Med; 1974 Oct; 84(4):546-58. PubMed ID: 4413781
    [No Abstract]   [Full Text] [Related]  

  • 10. [Production of a specific substrate-human plasminogen--for the quantitative determination of plasminogen activator in the blood plasma in sudden death].
    Khvatov VB; Petrenko OA
    Probl Gematol Pereliv Krovi; 1975 Jun; 20(6):57-60. PubMed ID: 1135191
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biochemistry of urokinase].
    Duckert F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(2):131-41. PubMed ID: 4106001
    [No Abstract]   [Full Text] [Related]  

  • 12. Isolation and properties of human vascular plasminogen activator.
    Allen RA; Pepper DS
    Thromb Haemost; 1981 Feb; 45(1):43-50. PubMed ID: 7195611
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inactivation and stabilization of urokinase fibrinolytic activity in vitro].
    Aĭsina RB; Mukhametova LI; Sazonova IIu; Varfolomeev SD
    Bioorg Khim; 1998 Jul; 24(7):544-8. PubMed ID: 9749317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amidase activity of urokinase. I. Hydrolysis of alpha-N-acetyl-L-lysine p-nitroanilide.
    Petkov D; Christova E; Karadjova M
    Thromb Diath Haemorrh; 1973 May; 29(2):276-85. PubMed ID: 4762254
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
    Moniwa N
    Pol J Pharmacol; 1996; 48(2):215-20. PubMed ID: 9112654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibition of tissue activator and urokinase by human plasma.
    Walker JE; Ogston D
    Thromb Haemost; 1982 Jun; 47(3):265-8. PubMed ID: 6180497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible and irreversible alterations of human plasminogen indicated by changes in susceptibility to plasminogen activators and in response to epsilon-aminocaproic acid.
    Thorsen S; Kok P; Astrup T
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):325-40. PubMed ID: 4450189
    [No Abstract]   [Full Text] [Related]  

  • 18. Facilitation of plasminogen activation by a plasmin substrate containing a lysyl residue.
    Machovich R; Owen WG
    Thromb Haemost; 1993 Nov; 70(5):864-6. PubMed ID: 8128447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
    Thorsen S; Astrup T
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
    Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.